CS logo
small CS logo
Area Vasta Romagna e IRST

Meldola (Fc), Italy
Hospital in Meldola
Via Piero Maroncelli, 40, 47014 Meldola FC

About Area Vasta Romagna e IRST


"Frutto dell’alleanza tra soggetti pubblici e appartenenti al privato sociale, l’Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST è riferimento nazionale in campo oncologico. La sua missione consiste nel promuovere e realizzare attività di cura, studio e ricerca, in particolare ricerca traslazionale. Operativo dal 2007 all’interno delle strutture dell'ex Ospedale Civile di Meldola (Forlì-Cesena) ha sedi a Forlì, Cesena e Ravenna (Radioterapia) ed è riconosciuto quale Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Area Vasta Romagna e IRST


During the past decade, Area Vasta Romagna e IRST conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Area Vasta Romagna e IRST" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Area Vasta Romagna e IRST


According to Clinical.Site data, the most researched conditions in "Area Vasta Romagna e IRST" are "CD20 Positive Diffuse Large B-cell Lymphoma" (1 trials), "Elderly Unfit Patients" (1 trials), "Follicular Lymphoma Grade 3A" (1 trials), "Follicular Lymphoma, Grade 1" (1 trials) and "Follicular Lymphoma, Grade 2" (1 trials). Many other conditions were trialed in "Area Vasta Romagna e IRST" in a lesser frequency.

Clinical Trials Intervention Types at Area Vasta Romagna e IRST


Most popular intervention types in "Area Vasta Romagna e IRST" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib-Rituximab-Bendamustine" (1 trials), "Ga101" (1 trials), "MBVD (Myocet+BVD)" (1 trials), "OFATUMUMAB" (1 trials) and "R-MANT" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Area Vasta Romagna e IRST


The vast majority of trials in "Area Vasta Romagna e IRST" are 6 trials for "All" genders.

Clinical Trials Status at Area Vasta Romagna e IRST


Currently, there are NaN active trials in "Area Vasta Romagna e IRST". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Area Vasta Romagna e IRST, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Area Vasta Romagna e IRST, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".